RYANODINE CONTRACTURE - A POTENTIALLY SPECIFIC INVITRO DIAGNOSTIC-TEST FOR MALIGNANT HYPERTHERMIA

被引：50
|
作者：
HOPKINS, PM
ELLIS, FR
HALSALL, PJ
机构：
来源：
BRITISH JOURNAL OF ANAESTHESIA | 1991年 / 66卷 / 05期
关键词：
HYPERTHERMIA; MALIGNANT; INVITRO TEST; PHARMACOLOGY; RYANODINE;
D O I：
10.1093/bja/66.5.611
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
In vitro contracture tests used currently for malignant hyperthermia (MH) do not possess absolute specificity. This is potentially a great problem in the study of the genetic approach which offers the best prospect for the development of a non-invasive diagnostic test for the condition. The calcium release channel of the sarcoplasmic reticulum has been proposed as the site of the MH defect. Ryanodine, which binds avidly to this channel, was shown to differentiate between muscle of MH susceptible and normal patients in terms of in vitro contracture response. This ryanodine contracture response is proposed as a potentially specific in vitro diagnostic test for MH.
引用
收藏
页码：611 / 613
页数：3
相关论文
共 50 条
  • [41] THE URINE PH - A POTENTIALLY MISLEADING DIAGNOSTIC-TEST IN PATIENTS WITH HYPERCHLOREMIC METABOLIC-ACIDOSIS
    RICHARDSON, RMA
    HALPERIN, ML
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (02) : 140 - 143
  • [42] DILTIAZEM AND NIFEDIPINE REDUCE THE INVITRO CONTRACTURE RESPONSE TO HALOTHANE IN MALIGNANT HYPERTHERMIA-SUSCEPTIBLE MUSCLE
    ADNET, PJ
    KRIVOSICHORBER, RM
    HAUDECOEUR, G
    REYFORD, HG
    ADAMANTIDIS, MM
    DUPUIS, BA
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (05): : 556 - 559
  • [43] A SUBSTITUTION OF CYSTEINE FOR ARGININE-614 IN THE RYANODINE RECEPTOR IS POTENTIALLY CAUSATIVE OF HUMAN-MALIGNANT HYPERTHERMIA
    GILLARD, EF
    OTSU, K
    FUJII, J
    KHANNA, VK
    DELEON, S
    DERDEMEZI, J
    BRITT, BA
    DUFF, CL
    WORTON, RG
    MACLENNAN, DH
    GENOMICS, 1991, 11 (03) : 751 - 755
  • [44] Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibility
    Ording, H
    Islander, G
    Bendixen, D
    Ranklev-Twetman, E
    ANESTHESIA AND ANALGESIA, 2000, 91 (02): : 452 - 457
  • [45] Malignant hyperthermia (MH): Positivity of the in vitro contracture test (ICVT) and associated neuromuscular alterations
    Tsanaclis, AMC
    Timo-Iaria, C
    Castro, I
    Silva, HCA
    BRAIN PATHOLOGY, 2000, 10 (04) : 537 - 537
  • [46] Caffeine-halothane contracture test and pharmacogenomics screening for investigation of malignant hyperthermia susceptibility
    Martinez de Soto, Lucia
    Rodriguez Mariblanca, Amelia
    Garcia Garcia, Irene
    Diaz Garcia, Lucia
    Queiruga Parada, Javier
    Monserrat Villatoro, Jaime
    Borobia Perez, Alberto M.
    Ramirez Garcia, Elena
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 42 - 42
  • [47] NO RELATIONSHIP BETWEEN FIBER TYPE AND HALOTHANE CONTRACTURE TEST-RESULTS IN MALIGNANT HYPERTHERMIA
    HEIMANPATTERSON, T
    FLETCHER, JE
    ROSENBERG, H
    TAHMOUSH, AJ
    ANESTHESIOLOGY, 1987, 67 (01) : 82 - 84
  • [48] THE DIAGNOSIS OF MALIGNANT HYPERTHERMIA SUSCEPTIBILITY .1. SIGNIFICANCE OF THE IN-VITRO CONTRACTURE TEST
    MORTIER, W
    BREUCKING, E
    ANAESTHESIST, 1993, 42 (10): : 675 - 683
  • [49] A COMPARISON OF THE CAFFEINE HALOTHANE MUSCLE CONTRACTURE TEST WITH THE MOLECULAR GENETIC DIAGNOSIS OF MALIGNANT HYPERTHERMIA
    MACKENZIE, AE
    ALLEN, G
    LAHEY, D
    CROSSAN, ML
    NOLAN, K
    METTLER, G
    WORTON, RG
    MACLENNAN, DH
    KORNELUK, R
    ANESTHESIOLOGY, 1991, 75 (01) : 4 - 8
  • [50] COMPARISON BETWEEN RYANODINE RECEPTOR RFLP DATA AND MUSCLE BIOPSY CONTRACTURE TESTING ASSIGNMENT IN MALIGNANT HYPERTHERMIA SUSCEPTIBLE KINDREDS
    GREENBERG, CR
    SERFAS, K
    PATEL, L
    BOSE, D
    GILLARD, EF
    WORTON, RG
    MACLENNAN, DH
    WROGEMANN, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 341 - 341
12345